| [1] |
Takahashi T，Ueno M，Azekura K，et al. Lateral node dissection and total mesorectal excision for rectal cancer［J］. Dis Colon Rectum，2000，43（Suppl 10）：59-68.
|
| [2] |
Hashiguchi Y，Muro K，Saito Y，et al. Japanese Society for Cancer of the Colon and Rectum（JSCCR）guidelines 2019 for the treatment of colorectal cancer［J］. Int J Clin Oncol，2020，25（1）：1-42.
|
| [3] |
Sugihara K，Kobayashi H，Kato T，et al. Indication and benefit of pelvic sidewall dissection for rectal cancer［J］. Dis Colon Rectum，2006，49（11）：1663-1672.
|
| [4] |
Kapiteijn E，Marijnen CA，Nagtegaal ID，et al. Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer［J］. N Engl J Med，2001，345（9）：638-646.
|
| [5] |
Sauer R，Liersch T，Merkel S，et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer：results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years［J］. J Clin Oncol，2012，30（16）：1926-1933.
|
| [6] |
Malakorn S，Chang GJ. Treatment of rectal cancer in the East and West：should it be different？［J］. Surgery，2017，162（2）：315-316.
|
| [7] |
Songphol M，Yun Y，Brian KB，et al. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation？［J］. Dis Colon Rectum，2019，62（10）：1158-1166.
|
| [8] |
Fujita S，Mizusawa J，Kanemisu Y，et al. Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer（JCOG0212）：A Multicenter，Randomized Controlled，Noninferiority Trial［J］. Ann Surg，2017，266（2）：201-207.
|
| [9] |
Komori K，Fujita S，Mizusawa J，et al. Predictive factors of pathological lateral pelvic lymph node metastasis in patients without clinical lateral pelvic lymph node metastasis（clinical stage II/III）：The analysis of data from the clinical trial（JCOG0212）［J］. Eur J Surg Oncol，2019，45（3）：336-340.
|
| [10] |
Ohue M，Fujita S，Mizusawa J，et al. Preoperative and postoperative prognostic factors of patients with stage II/III lower rectal cancer without neoadjuvant therapy in the clinical trial（JCOG0212）［J］. Jpn J Clin Oncol，2022，52（2）：114-121.
|
| [11] |
Fujita S，Akasu T，Mizusawa J，et al. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer（JCOG0212）：results from a multicentre，randomised controlled，non-inferiority trial［J］. Lancet Oncol，2012，13（6）：616-621.
|
| [12] |
Ito M，Kobayashi A，Fujita S，et al. Urinary dysfunction after rectal cancer surgery：Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer（Japan Clinical Oncology Group Study，JCOG0212）［J］. Eur J Surg Oncol，2018，44（4）：463-468.
|
| [13] |
Saito S，Fujita S，Mizusawa J，et al. Male sexual dysfunction after rectal cancer surgery：Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer：Japan Clinical Oncology Group Study JCOG0212［J］. Eur J Surg Oncol，2016，42（12）：1851-1858.
|
| [14] |
Tsukamoto S，Fujita S，Ota M，et al. Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer（JCOG0212）［J］. Br J Surg，2020，107（5）：586-594.
|
| [15] |
Oki E，Shimokawa M，Ando K，et al. Effect of lateral lymph node dissection for mid and low rectal cancer：An ad-hoc analysis of the ACTS-RC（JFMC35-C1）randomized clinical trial［J］. Surgery，2019，165（3）：586-592.
|
| [16] |
Heald RJ，Husband EM，Ryall RD. The mesorectum in rectal cancer surgery-the clue to pelvic recurrence？［J］. Br J Surg，1982，69（10）：613-616.
|
| [17] |
Akiyoshi T，Matsueda K，Hiratsuka M，et al. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer［J］.Ann Surg Oncol，2015，22 Suppl 3：S614-620.
|
| [18] |
Bae JH，Song J，Kim JH，et al. Lateral Lymph Node Size and Tumor Distance From Anal Verge Accurately Predict Positive Lateral Pelvic Lymph Nodes in Rectal Cancer：A Multi-Institutional Retrospective Cohort Study［J］. Dis Colon Rectum，2023，66（6）：785-795.
|
| [19] |
Schaap DP，Boogerd LSF，Konishi T，et al. Rectal cancer lateral lymph nodes：multicentre study of the impact of obturator and internal iliac nodes on oncological outcomes［J］. Br J Surg，2021，108（2）：205-213.
|
| [20] |
Uyama I，Sugioka A，Matsui H，et al. Laparoscopic lateral node dissection with autonomic nerve preservation for advanced lower rectal cancer［J］. J Am Coll Surg，2001，193（5）：579-584.
|
| [21] |
Lim HK，Kim M，Park JW，et al. Laparoscopic versus open lateral pelvic lymph node dissection in locally advanced rectal cancer：multicentre retrospective cohort study［J］. BJS Open，2022，6（3）：zrac068.
|
| [22] |
Tang J，Zhou S，Zhao W，et al. Short-and long-term outcomes of laparoscopic versus open selective lateral pelvic lymph node dissection for locally advanced middle-low rectal cancer：Results of a multicentre lateral node study in China［J］. Colorectal Dis，2022，24（11）：1325-1334.
|
| [23] |
Yamaguchi T，Konishi T，Kinugasa Y，et al. Laparoscopic Versus Open Lateral Lymph Node Dissection for Locally Advanced Low Rectal Cancer：A Subgroup Analysis of a Large Multicenter Cohort Study in Japan［J］. Dis Colon Rectum，2017，60（9）：954-964.
|
| [24] |
Jiang H，Liu H，Li A，et al. Laparoscopic lateral lymph node dissection in two fascial spaces for locally advanced lower rectal cancer［J］. World J Gastroenterol，2021，27（24）：3654-3667.
|